Advisor Group’s Titan Pharmaceuticals TTNP Stock Holding History

Advisor Group’s Portfolio TTNP Stock Details TTNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Hold	1	–	–	﹤0.01%	5449
2019 Q3	$0	Hold	1	–	–	﹤0.01%	5423
2019 Q2	$0	Hold	1	–	–	﹤0.01%	5362
2019 Q1	$1K	Hold	1	–	–	﹤0.01%	5121
2018 Q4	$0	Hold	1	–	–	﹤0.01%	5236
2018 Q3	$0	Hold	1	–	–	﹤0.01%	5222
2018 Q2	$2K	Hold	1	–	–	﹤0.01%	4701
2018 Q1	$2K	Buy	+1	New	+$4.18K	﹤0.01%	4718
2017 Q4	–	Hold	0	–	–	–	4717
2017 Q3	–	Hold	0	–	–	–	4450
2017 Q2	–	Hold	0	–	–	–	4537
2017 Q1	–	Hold	0	–	–	–	4309
2016 Q4	–	Hold	0	–	–	–	4250
2016 Q3	–	Hold	0	–	–	–	4088
2016 Q2	–	Hold	0	–	–	–	4126

Other funds holding TTNP

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

CWM

Cornerstone Wealth Management St. Peters, Missouri $2.33B AUM 25.21% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Advisor Group's TTNP Position: Q4 2019 in Review

Advisor Group held its Titan Pharmaceuticals (TTNP) position steady in Q4 2019 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5449.

Advisor Group first reported a position in TTNP in Q1 2018 and has held it in 8 quarters since. The position peaked at $2K in Q2 2018. 21 funds tracked by Wall St. Rank hold TTNP as of Q4 2019.

Advisor Group held 1 share of Titan Pharmaceuticals worth $0 as of Q4 2019.
Advisor Group left its Titan Pharmaceuticals share count unchanged in Q4 2019.
Titan Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5449 holding.
Advisor Group first reported a position in Titan Pharmaceuticals in Q1 2018 and has held it in 8 quarters since.
Advisor Group's Titan Pharmaceuticals position peaked at $2K in Q2 2018.
21 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.